Federal health officials are investigating a multistate Salmonella outbreak linked to a dietary supplement product marketed as a greens powder. The Food and Drug Administration said the investigation involves Live it Up-brand Super Greens supplement powder with expiration dates from 08/2026 to 01/2028, including original and wild berry flavors. The product is primarily sold online through the company’s website and other large e-commerce platforms, a distribution pattern that can quickly spread risk across many states.
In its latest public update, the FDA said the outbreak involves Salmonella Typhimurium infections and noted that public health partners reported 45 illnesses across 21 states, with 12 hospitalizations and no deaths reported. Illness onset dates ranged from August 22, 2025, through December 30, 2025, which suggests exposures may have occurred over an extended period before the cluster was fully identified. Investigators rely on interviews and lab sequencing to determine which cases are part of the same outbreak strain.
The FDA said it recommended that the manufacturer, Superfoods, Inc. doing business as Live it Up, recall the affected products, and reported that the firm agreed to initiate a voluntary recall on January 14, 2026. The CDC has also posted outbreak pages explaining that reported case totals are often an underestimate, because many people recover without medical care and are never tested, and because it can take weeks for cases to be confirmed and linked through surveillance systems.
Salmonella infection can cause diarrhea, fever and abdominal cramps, typically starting 12 to 72 hours after exposure and lasting several days. Young children, older adults and people with weakened immune systems are at higher risk of severe illness. Regulators advised consumers and retailers not to consume, sell or serve the specified products, and to throw them away or return them. Officials also recommended cleaning and sanitizing surfaces or containers that may have come into contact with the powder to reduce cross-contamination risk.
Investigators are continuing traceback work to identify how contamination may have occurred and whether additional products could be implicated. The FDA said its advisory will be updated as new information becomes available, and public health agencies encouraged anyone who develops symptoms after consuming the product to seek medical advice and report illness to help improve outbreak detection.